Status:
COMPLETED
Patient Navigation in Cancer Survivorship at a Safety Net Institution
Lead Sponsor:
Boston Medical Center
Collaborating Sponsors:
Harvard Pilgrim Health Care
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study seeks to enroll patients receiving a Survivorship Care Plan following curative therapy for cancer. Participants will be randomly assigned to receive usual care or to be followed by a Patien...
Detailed Description
This study seeks to enroll patients receiving a Survivorship Care Plan following curative therapy for cancer. Participants will be randomly assigned to receive usual care or to be followed by a Patien...
Eligibility Criteria
Inclusion
- Stage I, II, III or IVa Cancer diagnosis (may include Solitary plasmacytoma, Diffuse Large B-Cell Lymphoma (DLBCL), ductal carcinoma in situ (DCIS) of the breast)
- Completed treatment with curative intent within the past 12 months. (May be on maintenance therapy.)
Exclusion
- Distant Metastatic disease
- Non-curable disease
- Recurrence of disease prior to enrollment
- Require ongoing navigation from the treatment navigator
- Enrolled/active in another randomized study (Project SUPPORT)
Key Trial Info
Start Date :
October 16 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 10 2020
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT03271099
Start Date
October 16 2017
End Date
September 10 2020
Last Update
September 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Medical Center
Boston, Massachusetts, United States, 02118